| Name | 1-Cyclopropyl-3-{3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea |
|---|---|
| Synonyms |
T9283
AT9283 1-Cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}harnstoff AT9283 //BP (2S)-2-Hydroxypropanoic acid compd. with N-cyclopropyl-N'-[3-[6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea AT-9283 L-Lactate 1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea (S)-2 AT 9283, (2S)-2-hydroxy-propanoic acid salt |
| Description | AT9283 lactic acid is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM). AT9283 lactic acid inhibits growth and survival of multiple solid tumors in vitro and in vivo[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Aurora A:3 nM (IC50) Aurora B:3 nM (IC50) JAK3:1.1 nM () JAK2:1.2 nM () ABL(T315I):4 nM () |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H29N7O5 |
| Molecular Weight | 471.51 |
| Exact Mass | 381.191315 |
| LogP | 0.92 |
| Index of Refraction | 1.715 |